HIV Alert: Options for Integrase Inhibitor Therapy Following Recent Drug Approvals

On February 27 or March 1, join us for the sixth Webinar in a series providing targeted insights into the latest developments in HIV care!

In these live, 45-minute, CME/CE/CPE-certified Webinars, Paul E. Sax, MD, and Brian Wood, MD, will provide expert insight on INSTI-based ART options following recent drug approvals.


  • What’s new?
    • Bictegravir/FTC/TAF approved for first-line and maintenance therapy
    • Dolutegravir/rilpivirine approved for maintenance therapy
  • Moving forward: best practices in the use of INSTI-based regimens
  • Question and answer session


Date / Time
Event Details


Paul E. Sax, MD

Clinical Director
HIV Program and Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Brian Wood, MD

Associate Professor of Medicine
Division of Allergy and Infectious Disease
University of Washington
Seattle, Washington


Program Overview
A series of live Webinars in which expert faculty review key data and provide perspectives on the impact of new developments in HIV care.

Goal Statement
The goal of this activity is to improve participants’ confidence and competence in incorporating best practices and emerging data into their HIV patient care strategies.

Target Audience
This program is intended for physicians, registered nurses, pharmacists, and other healthcare professionals involved in the management of patients at risk of or infected with HIV.

Learning Objectives

  • Incorporate the results of recent clinical studies and regimen approvals as appropriate when devising treatment strategies for patients with HIV infection


Physician Continuing Medical Education

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Accreditation Statement
Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation
0.7 contact hour may be earned for successful completion of this activity.

A statement of credit will be issued automatically only upon completion of the online activity evaluation form.

Pharmacist Continuing Education

ACPE logo

Accreditation Statement
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation
This program has been assigned ACPE Universal Activity #0797-9999-18-052-L02-P. This program is designated for up to 0.75 contact hours (0.075 CEUs) of continuing pharmacy education credit.

Type of Activity: Knowledge

For Pharmacists: Pharmacists have up to 30 days to complete the evaluation and claim credit for participation so that information can be submitted to CPE Monitor as required.

Disclosure of Conflicts of Interest 
The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Annenberg Center for Health Sciences at Eisenhower policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.